I have conducted in-depth clinical research in minimally invasive surgery for congenital heart disease and the treatment of complex neonatal congenital heart disease. For many consecutive years, I have performed over 1,000 cases of cardiopulmonary bypass surgery for congenital heart disease annually. I pioneered the "modified subaxillary small incision technique," achieving comprehensive minimally invasive treatment for a wide range of common and some complex congenital heart diseases across all age groups, from neonates to adults. Currently, I serve as a member of the Pediatric Cardiac Surgery Group of the 11th Committee of the Pediatric Surgery Branch of the Chinese Medical Association, a youth member of the Congenital Heart Disease Professional Committee of the National Cardiovascular Disease Expert Committee, a youth member of the Asian Association of Pediatric and Congenital Heart Surgery (AAPCHS), a standing committee member of the Structural Heart Disease Professional Committee of the Chinese Research Hospital Association, a member of the Extracorporeal Life Support and Circulation Professional Committee of the Chinese Research Hospital Association, a member of the Cardiovascular Surgery Professional Committee of the Chinese Non-Government Medical Institutions Association, a youth editorial board member of the *Chinese Journal of Applied Clinical Pediatrics*, and a youth editorial board member of the *Chinese Journal of Practical Diagnosis and Therapy*. I consecutively won first place in the finals of the Young Physician Congenital Heart Surgery Competition at the China Minimally Invasive Cardiovascular Conference in 2024 and 2025. Overseas training: I have studied and trained in the diagnosis and treatment techniques for pediatric congenital heart disease at the University Hospital of Vienna in Austria and the Children's Hospital of Philadelphia in the United States. Main research directions: Minimally invasive surgical treatment of congenital heart disease; integrated prenatal and postnatal management and surgical treatment of complex neonatal congenital heart disease; rapid postoperative recovery management for complex neonatal congenital heart disease; and 3D printing-guided individualized surgical design and optimization.